Sign In
Buy AGRX
$1.51
+0 (+0%)
At Close: Nov 25, 2024
Sep 30, 2020 (WiredRelease via Comtex) --
The latest research report provides a complete assessment of the Global Intrauterine Contraceptive Devices market...
Wisconsin Heroes: Tell Us Who's Made A Difference In Your Life!
09:05pm, Friday, 11'th Sep 2020
The helpers are the people who make life better. Nominate your Local Heroes to give them the recognition they deserve, presented by Ring.
Agile Therapeutics: Taking A Victory Lap While We Wait For Twirla's Commercial Launch
08:28pm, Monday, 31'st Aug 2020
My original Agile Therapeutics investment thesis and plan have worked out exactly how I planned them. Now, I am looking to take a victory lap ahead of Twirla's commercial launch.
Employee Says Sign Restrictions May Impact Palatine Businesses
03:59pm, Friday, 28'th Aug 2020
An employee at a Palatine business voiced his concern over the impact of sign restrictions put in place by the village during the pandemic.
How to build a spud tower: an edible treasure hunt with a guaranteed bounty
05:30pm, Monday, 24'th Aug 2020
It doesn’t take much effort to grow your own potatoes, and across most of Australia, now is the perfect time to plant them
Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
12:00pm, Monday, 17'th Aug 2020
PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner, MD, MBA, to
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
08:02pm, Tuesday, 11'th Aug 2020
PRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will p
Agile Therapeutics Reports Second Quarter 2020 Financial Results
08:01pm, Tuesday, 11'th Aug 2020
Twirla® on Track for Commercial Launch in Fourth Quarter 2020 $87.2 Million in Cash and Cash Equivalents as of June 30, 2020 Management to Host Conference Call at 4:30 PM ETPRINCETON, N.J., Aug. 11,
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020
11:30am, Tuesday, 21'st Jul 2020
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., July 21, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company,.
C4 Therapeutics Announces the Additions of William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer
12:00am, Wednesday, 15'th Jul 2020
C4 Therapeutics Announces the Additions of William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer
Hedge Funds Have Never Been This Bullish On Agile Therapeutics Inc (AGRX)
07:52pm, Monday, 29'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
How Agile Therapeutics (AGRX) Stock Stands Out in a Strong Industry
12:30pm, Tuesday, 23'rd Jun 2020
Agile Therapeutics (AGRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
BioMarin's Hemophilia Data, And Other News: The Good, Bad And Ugly Of Biopharma
10:46am, Friday, 19'th Jun 2020Agile Therapeutics to Join Russell 3000® and 2000® Indexes
12:00pm, Tuesday, 16'th Jun 2020
PRINCETON, N.J., June 16, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the Company will be added to the Russell 3000® and.
